Marina Yannakoudakis MEP views the future of biomedical research
Marina Yannakoudakis MEP met Cancer Research UK scientists in London today to learn about the charity’s world class research and the future vision for biomedical advances in the UK.
The MEP for London witnessed firsthand the groundbreaking scientific research carried out by scientists and doctors at the London Research Institute. She then visited the site of the new Francis Crick Institute (The Crick) which will be the largest bio-medical research laboratory in Europe when it opens in 2015.
Marina Yannakoudakis MEP said: “This was a great opportunity to see the fantastic work Cancer Research UK is doing and the contribution that the new Crick Institute will make to the future of biomedical research in the UK. It highlighted why it’s so important we continue to support groundbreaking research that will help ensure cancer patients have access to the best possible treatment.”
Cancer Research UK’s current research centre in London, the LRI, has an international reputation for basic cancer biology research, and is due to move to the Crick’s laboratories in 2015. The Crick will be a world-class centre for interdisciplinary medical sciences, research and innovation. It will serve to stimulate scientists and medical professionals to work together in inspiring new ways.
Sara Osborne, Head of Policy at Cancer Research UK, said: “We were delighted that Marina Yannakoudakis had the opportunity to witness first-hand the exciting development of the Francis Crick Institute and learn how the pioneering life-saving research the Crick will undertake will prove to be a real game changer in our fight against cancer.”
Cancer survival rates in the UK have doubled in the last forty years and Cancer Research UK’s work has been at the heart of that progress. Thanks to the generosity of its supporters, the charity was able to spend more than £332 million of research in 2011/12, supporting the work of more than 4,000 researchers, doctors and nurses.